ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
GET MORE DETAILS ON OUR SOLUTIONS
-
![GettyImages-891264822 planning, meeting]( "The Benefits Of Engaging In Pre-Approval Information Exchange (PIE)")
Explore the top 3 insights on the impact of pre-approval communication and learn why healthcare decision makers want more pre-approval resources and engagement from manufacturers.
FEATURED INSIGHTS
-
![GettyImages-1371695227 japan, market access]( "HTA In Japan: The Glass Remains Half Full (For Now)")
While Japan's current HTA system is seen as pro-innovation, potential reforms in 2026 could expand its scope, creating uncertainty for manufacturers in one of the world's largest markets.
-
![GettyImages-1622900627 france, french flag, healthcare]( "Early Access Program In France: How Much Of An Opportunity Is It?")
Navigating France’s Early Access Program is more complex than ever. Amid declining approval rates and mandatory data collection, here’s what pharmaceutical companies need to know about the changing landscape.
-
![Cencora - Oriol]( "Insights From Pharma 2025: The Impact Of The European Health Data Space (EHDS) Reform On Healthcare Systems")
Experts explore the revolutionary European Health Data Space, a reform designed to enhance patient data control, streamline care across borders, and unlock new opportunities for medical research.
-
![Cencora - Meglic]( "Insights From Pharma 2025: Driving Commercial Success In Pharma: The Role Of Patient Journey Acceleration And Digital Innovation")
From predictive AI to the European Health Data Space, industry experts discuss how digital transformation is reshaping patient care and creating new pathways for commercial success in pharmaceuticals.
-
![Cencora - Duman]( "Insights From Pharma 2025: Elevating Patient Engagement")
A significant gap exists between drug development and patient use. Industry veteran Mark Duman explains why listening to patients is the key to closing it and improving health outcomes.
-
![Cencora - Justine Rochone]( "Insights From Pharma 2025: Leadership In Pharma – Empowering Change Through Innovative Thinking")
What does it take to lead in today's evolving pharmaceutical landscape? Insights from Pharma 2025 reveal that empowering teams through trust, experimentation, and a shared purpose is key.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
VIDEOS AND WEBINARS
-
![Cencora - Orchestration]( "Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management")
Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order ManagementStreamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.
-
![Strategic Logistics]( "Crafting Scalable Solutions For Maximum Reach And Success")
Crafting Scalable Solutions For Maximum Reach And SuccessIs your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
![Maximizing Impact]( "Maximizing Impact: Strategies For Building Robust Patient Support Programs")
Maximizing Impact: Strategies For Building Robust Patient Support ProgramsPanelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
![Navigating Special Regulatory Pathways For Advanced Therapy Development Success]( "Navigating Special Regulatory Pathways For Advanced Therapy Development Success")
Navigating Special Regulatory Pathways For Advanced Therapy Development SuccessDon't let regulatory hurdles slow you down. Learn from leading experts about special designations like RMAT and PRIME to accelerate your advanced therapy development and ensure success.
-
![The Power Of Integrated Distribution Strategies]( "The Power Of Integrated Distribution Strategies")
The Power Of Integrated Distribution StrategiesDiscover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients.
WHITE PAPERS
-
![GettyImages-891264822 planning, meeting]( "Why An Integrated Approach Ensures Smooth Entry Into The European Market")
Why An Integrated Approach Ensures Smooth Entry Into The European MarketSimplify your EU launch and boost returns. Learn how to manage regulatory hurdles, access a huge patient population, and gain end-to-end commercial support.
-
![GettyImages-2036497698 clinical lab]( "A CFO's Guide To Driving Growth")
A CFO's Guide To Driving GrowthNavigate the evolving biotech landscape and secure venture capital with insights on strategic partnerships and investor expectations.
PODCASTS
-
![Digital-marketing-GettyImages-1051659276]( "Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty Pharmacy")
Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty PharmacyTune in as experts discuss how biopharma companies can effectively engage healthcare decision-makers in the evolving digital landscape.
-
![Cencora PharmaLex - PlX talks 30]( "An Overview Of Contamination Control Strategy (CCS)")
An Overview Of Contamination Control Strategy (CCS)Join experts Londa Ritchey and Patrick Nieuwenhuizen as they explore the key role of a contamination control strategy in Annex 1 for ensuring patient safety and continuous manufacturing improvement.
-
![Cencora - PharmaLex Talks 27]( "Assessing Gaps And Achieving Compliance With Annex 1")
Assessing Gaps And Achieving Compliance With Annex 1In this podcast episode on Annex 1 compliance and gap assessment, Patrick Nieuwenhuizen shares his insights and expertise gleaned from extensive experience in pharmaceutical regulation and compliance.
-
![Cencora - PharmaLex Talks 26]( "Navigating The Process Of Technology Transfer")
Navigating The Process Of Technology TransferOlena Chervonenko, Associate Director Quality Management and Compliance at PharmaLex, provides deeper insights into technology transfer and essential factors for achieving success.
-
![Cencora - PharmaLex Talks 16]( "How The Quality Culture Impacts GMP Activity")
How The Quality Culture Impacts GMP ActivityLonda Ritchey shares invaluable insights derived from her extensive experience, shedding light on the pivotal role of fostering a strong quality culture in maintaining GMP compliance.
